Heregulin-beta1 promotes the activation of
p21-activated kinase 1 (Pak1) and the motility and invasiveness of
breast cancer cells. In this study, we identified
vascular endothelial growth factor (
VEGF) as a gene product induced by heregulin-beta1. The stimulation by heregulin-beta1 of
breast cancer epithelial cells induced the expression of the
VEGF mRNA and
protein and its promoter activity. Heregulin-beta1 also stimulated angiogenesis in a
VEGF-dependent manner.
Herceptin, an anti-HER2 antibody inhibited heregulin-beta1-mediated stimulation of both
VEGF expression in epithelial cells and angiogenesis in endothelial cells. Because the activation of Pak1 and
VEGF expression are positively regulated by heregulin-beta1, we hypothesized that Pak1 regulates
VEGF expression, and hence explored the role of Pak1 in angiogenesis. We provide new evidence to implicate Pak1 signaling in
VEGF expression. Overexpression of a
kinase-dead K299R Pak1 leads to suppression of
VEGF promoter activity, as well as
VEGF mRNA expression and secretion of
VEGF protein. Conversely,
kinase-active T423E Pak1 promotes the expression and secretion of
VEGF. Furthermore, expression of the heregulin-beta1 transgene,
HRG, in harderian
tumors in mice enhances the activation of Pak1 as well as expression of
VEGF and angiogenic marker
CD34 antigen. These results suggest that heregulin-beta1 regulates angiogenesis via up-regulation of
VEGF expression and that Pak1 plays an important role in controlling
VEGF expression and, consequently,
VEGF secretion and function.